MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
ASX:MVPPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 96.6% of what they think they own, once every option and right converts.
No major dilution pressure signals in current disclosures
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED has 113M ordinary shares as of August 2024. The company has not lodged any new share-issuance filings since January 2024 and has not raised capital in the past 24 months. Options and rights on issue could convert into 4M new shares, representing 3.5% of the current share count; no options are currently in the money. An expiry date for these securities is not on record. At the June 2026 quarter end, the company reported A$23.6M in available cash, with positive net cash flow in that period meaning no funding runway figure applies. No proposed securities issues are currently pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 14 May 2026 | 3H · cancellation | MVP : ORDINARY FULLY PAID | 112.7M | Appendix 3H |
| 20 Apr 2026 | 3H · cancellation | MVP : ORDINARY FULLY PAID | 112.7M | Appendix 3H |
| 2 June 2025 | 3G · unquoted | ORDINARY FULLY PAID | 112.7M | Appendix 3G |
| 2 Oct 2024 | 3H · cancellation | MVP : ORDINARY FULLY PAID | 112.7M | Appendix 3H |
| 27 Aug 2024 | 2A · quoted issue | MVP : ORDINARY FULLY PAID | 112.7M | Appendix 2A |
Capital raises
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered392k · 0.3% of sharesOptions and warrants — they convert when the share price clears their exercise price.No exercise price is on record for any of it, so none of it can be called in or out of the money.
- Condition-triggered3.5M · 3.1% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 0 priced, 3.9M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 3.9M of it converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| MVPAA | Options | Price-triggered | — | — | 392k | Filing |
| MVPAD | Performance rights | Condition-triggered | — | — | 3.5M | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 30 Oct 2025 | Russell Basser | Buy on-market | 40k | — | — | $28k | 3Y notice |
| 30 Sept 2025 | Mark Fladrich | Buy | 63k | — | — | — | 3Y notice |
| 22 Sept 2025 | Paul Townsend | Buy on-market | 25k | — | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.